LOS ANGELES--(Enterprise WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical firm, introduced that on June 3, 2022, the Compensation Committee of...
Puma
Merck & Co., Inc. (NYSE:MRK – Get Rating) and Puma Biotechnology (NASDAQ:PBYI – Get Rating) are both medical companies, but...